May I add imo.. 10k got nothing to do with the voting results... PR/8k can be announced at anytime furthermore the 10k can drop separately at anytime. Since 1st of April it has been complete silence. If you looked at other spac a PR come after votes are approved...take djt for example or the most recent A SPAC I "NewGenIvf" voted March 4th

Pr/news March 5th
"NewGenIvf and A SPAC I Announce Shareholder Approval of Business ...
Mar 5, 2024 —

See link for yourself
https://www.spacresearch.com/symbol/ASPAU

Taking notes 👀👀

Fillings says it all

"On November 4, 2023, the Company entered into Amendment No. 1 to the Business Combination (the “Amendment”) with the other parties thereto. The Amendment extends the termination date under the Business Combination Agreement from November 4, 2023 to March 4, 2024 (the “Termination Date”); provided, further, that (i) the right to terminate the Business Combination Agreement will not be available to the Company if any Company party’s breach of any of its covenants or obligations under the Business Combination Agreement will have proximately caused the failure to consummate the transactions contemplated by the Business Combination Agreement on or before the Termination Date, and (ii) the right to terminate the Business Combination Agreement will not be available to the Company if the Company’s breach of its covenants or obligations under the Business Combination Agreement will have proximately caused the failure to consummate the transactions contemplated by the Business Combination Agreement on or before the Termination Date."

119

Another 35k paid to extend into March 4 termination deadline

All S/4 updates "no longer be necessary" lol

Who's having a hard time comprehending below?

"NOTE 11 — SUBSEQUENT EVENTS

On January 11, 2023, a shareholder repaid a $250,000 short-term loan to the Company.

On May 30, 2023, the Company entered into a Business Combination Agreement with Redwoods Acquisition Corp., a Delaware corporation (“Redwoods”), and Redwoods wholly owned subsidiary ANEW MEDICAL Sub, Inc., a Wyoming corporation (“Merger Sub”), The Business Combination Agreement and the transactions contemplated thereby were approved by the board of directors of each of Redwoods and the Company.

The Business Combination Agreement provides, among other things, on the Closing Date, upon the terms and conditions set forth herein and in accordance with the applicable provisions of the Wyoming Business Corporations Act (the “WBCA”), Merger Sub will merge with and into the Company, with the Company as the surviving company in the Merger and, after giving effect to such merger, a wholly owned Subsidiary of Redwoods, and each Company Share will be converted into the right to receive the Merger Consideration, on the terms and subject to the conditions set forth in the Business Combination Agreement.

The Business Combination is expected to close, and the related S4 is expected to be effective, in the third calendar quarter of 2023, but in no event later than December 4, 2023, following the receipt of the required approval by the stockholders of Redwoods and the Company, approval by the Nasdaq Stock Market (“Nasdaq”) of the initial listing application of the combined company filed in connection with the Business Combination, and the fulfillment of other customary closing conditions.

The Company’s pending name change to ANEW MEDICAL Inc. and a reverse split will *no longer be necessary* as the combined company will be renamed ANEW MEDICAL Inc. on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock.

The Company evaluated all events or transactions that occurred through March 23, 2023. During this period, the Company did not have any material recognizable subsequent events.

F-81

Newwwesssssss

Newsssssssss

Newsss company shows no slowing down

940 new KIOSK in 24 states that's 39 each States spread out
Supply+demand+halving in April

$BTM could've said it any better "Provide Greater Access for Users to Fund Their Bitcoin Wallet with Cash" meanwhile blackrock hoarding at 5k per day for 3 days total of 16k before halving deadline set for April 19, 2024. If you don't see the Big Picture Demand + low supply = inflatable price

"Bitcoin Depot Plans to Install Kiosks in Roughly 940 Stores Across 24 US States to Provide Greater Access for Users to Fund Their Bitcoin Wallet with Cash"

ANEW MEDICAL, INC. entered into a definitive merger agreement to acquire Redwoods Acquisition Corp. from Redwoods Capital LLC and others for approximately $110 million in a reverse merger transaction.
May 29, 2023

ANEW MEDICAL, INC. (OTCPK:LEAS) entered into a definitive merger agreement to acquire Redwoods Acquisition Corp. (NasdaqGM:RWOD) from Redwoods Capital LLC and others for approximately $110 million in a reverse merger transaction on May 30, 2023. As per the terms of the transaction, the Company will acquire all of the outstanding equity interests of ANEW in exchange for shares of the Company's common stock, par value $0.0001 per share (the “ Common Stock ”), based on an implied ANEW equity value of $60,000,000, to be paid to ANEW stockholders at the effective time of the Merger.

In addition, certain ANEW stockholders will be issued additional shares of the Company's Common Stock (the “ Contingent Consideration Shares ”), which will be issued as follows: (i) 2,000,000 Contingent Consideration Shares upon the Company achieving a closing price equal to or exceeding $12.50; (ii) 2,000,000 Contingent Consideration Shares upon the Company achieving a closing price equal to or exceeding $15.00; and (iii) 1,000,000 Contingent Consideration Shares upon the Company achieving a closing price equal to or exceeding $20.00 for 10 trading days within a 20-day trading period in the first five years following the Closing. The pro forma enterprise value of the combined company is up to $94 million, which includes up to $54 of cash held in the trust account of Redwoods, which is subject to redemption by Redwoods stockholders. These values exclude up to 5 million of additional earn-out shares that would be issued to ANEW stockholders if applicable stock performance-based requirements are met.

The proposed business combination contemplates that ANEW's stockholders will roll 100% of their equity into the combined company and will be eligible to receive additional shares pursuant to an earn-out based on the combined company's future stock performance. ANEW MEDICAL shall pay Redwoods a termination fee of $500,000 and vice-versa.

"The proposed business combination contemplates that ANEW's stockholders will roll 100% of their equity into the combined company and will be eligible to receive additional shares pursuant to an earn-out based on the combined company's future stock performance."

S4 December 29, 2023 this is what the updated s4 is about "PIPE waiver"

"Q. What conditions must be satisfied to complete the Business Combination?

A. There are a number of closing conditions in the Business Combination Agreement, including the expiration or termination of the applicable waiting period under the HSR Act and the approval by the stockholders of Redwoods of the business combination proposal, the Nasdaq proposal, the charter proposal, the incentive plan proposal and the director proposal. The receipt of proceeds of a PIPE Investment is not a closing condition however and there can be no assurance that one or more PIPE Investments will occur by the Closing of the Business Combination. For a summary of the conditions that must be satisfied or waived prior to completion of the business combination, please see the section entitled “Proposal No. 1 — The Business Combination Proposal — Certain Agreements Related to the Business Combination — Business Combination Agreement.”

Q. Are there any arrangements to help ensure that Redwoods will have sufficient funds, together with the proceeds in its trust account and from the PIPE Investment, to fund the aggregate purchase price?

A. The Business Combination Agreement provides that, prior to the Closing, ANEW shall enter into definitive agreements on terms and conditions satisfactory to Redwoods (the “PIPE Subscription Agreements”) with certain investors (the “PIPE Investors”) pursuant to which such investors, upon the terms and subject to the conditions set forth therein, will purchase shares of Redwoods Common Stock at a purchase price of ten dollars ($10.00) per share (the “PIPE Investment”); provided that the proceeds of the PIPE Investment will be equal to an aggregate of at least five million dollars ($5,000,000) immediately prior to the Closing. As of the date of this proxy statement, Redwoods and ANEW have not entered into any agreements relating to transaction financing for the proposed Merger nor have any PIPE Investors been identified. The management teams of Redwoods and ANEW are continuing to analyze the available financing options based on cost, amount made available under the financing and future effects that any financing would have on the capitalization of the Combined Company. Redwoods, Redwoods’ sponsor, ANEW and their respective directors, officers and affiliates have no prior relationships with any of the potential financing sources being considered in connection with the Merger. Redwoods will disclose the terms of any PIPE Investment and any other financing it obtains in a future amendment to this proxy statement/prospectus. Five million dollars ($5,000,000) is the minimum required cash commitment to complete the merger. For more information about the PIPE Investment, please see the section titled “Proposal No. 1 — The Business Combination Proposal — PIPE Investment.”

Please read the fillings it is helpful to do a "find in page" by utilizing your search tool within the fillings and search the fillings these wordings

Reverse split
Contemplated
Not declared effective
No longer be necessary
Waiver
Closed
Termination

These fillings are public records. You decide what benefits you

I hope this is helpful.

$LEAS "Subsequent Events "

Whoever having a hard time comprehending what this means I'm happy to help
What is occuring?
What is coming later or after?
"No longer be necessary"

SUBSEQUENT definition in American English
1. occurring or coming later or after. subsequent events. 2. following in order or succession; succeeding.

"The Company’s pending name change to ANEW MEDICAL Inc. and a reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc. on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock.

"the Company did not have any material recognizable subsequent events."

This latest Subsequent Events dated January 3, 2024 s4

"NOTE 11 — SUBSEQUENT EVENTS

On January 11, 2023, a shareholder repaid a $250,000 short-term loan to the Company.

On May 30, 2023, the Company entered into a Business Combination Agreement with Redwoods Acquisition Corp., a Delaware corporation (“Redwoods”), and Redwoods wholly owned subsidiary ANEW MEDICAL Sub, Inc., a Wyoming corporation (“Merger Sub”), The Business Combination Agreement and the transactions contemplated thereby were approved by the board of directors of each of Redwoods and the Company.

The Business Combination Agreement provides, among other things, on the Closing Date, upon the terms and conditions set forth herein and in accordance with the applicable provisions of the Wyoming Business Corporations Act (the “WBCA”), Merger Sub will merge with and into the Company, with the Company as the surviving company in the Merger and, after giving effect to such merger, a wholly owned Subsidiary of Redwoods, and each Company Share will be converted into the right to receive the Merger Consideration, on the terms and subject to the conditions set forth in the Business Combination Agreement.

The Business Combination is expected to close, and the related S4 is expected to be effective, in the third calendar quarter of 2023, but in no event later than December 4, 2023, following the receipt of the required approval by the stockholders of Redwoods and the Company, approval by the Nasdaq Stock Market (“Nasdaq”) of the initial listing application of the combined company filed in connection with the Business Combination, and the fulfillment of other customary closing conditions.

The Company’s pending name change to ANEW MEDICAL Inc. and a reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc. on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock.

The Company evaluated all events or transactions that occurred through March 23, 2023. During this period, the Company did not have any material recognizable subsequent events."

Gold Reserve Act of 1934
by G Richardson · Cited by 25 — Signed by President Franklin D. Roosevelt

Blackrock stripping miners to the bones
11500 btc in two days. Halving+demand = ETF substantial gains


This time Bitcoin Reserve Act 2024
Same happening all over again

"Rationale. The stated reason for the order was that hard times had caused "hoarding" of gold, stalling economic growth and worsening the depression as the US was then using the gold standard for its currency."


Notes:

"Historical data from the launch of the first gold ETF in the US in November 2004 provides insights into a potential Bitcoin ETF's impact. Gold's price steadily increased from $375 in May to $442 on the ETF launch day, reaching $454 shortly after due to substantial inflows."

"inflows
a large amount of money, people, or water, that moves or is transferred into a place."

"$1.4B Inflows Into Spot Bitcoin ETF After First Two Trading Sessions"

January 3, 2024 filling s4-
"reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc."


"The Company’s pending name change to ANEW MEDICAL Inc. and a reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc. on the Business Combination closing date and the Company’s outstanding common stock and preferred stock will be converted into 6,000,000 shares of the combined company’s common stock."

Y'all CAN LOAD NOW

"When do you expect the business combination to be completed?"

A. It is currently anticipated that the business combination will be consummated promptly following the Redwoods special meeting which is set for [•], 2023, subject to the satisfaction of customary closing conditions; however, such meeting could be adjourned, as described above. For a description of the conditions to the completion of the business combination, please see the section entitled “Proposal No. 1 — The Business Combination Proposal — The Business Combination Agreement — Conditions to Closing of the Transactions.”

"Effect of Klotho CRISPR activation and Klotho CRISPR/Cas9 KO plasmids transfection into Caco-2 cells on cell viability and apoptosis."

"The two sgRNAs enhanced Klotho expression at both the gene and protein levels. Our results show the feasibility of gene therapy for targeting Klotho using CRISPR technology."


https://stocktwits.com/StockRoomBully/message/556952019

Pono shareholders approved merger. This is ONLY for reference to Pono closed BCA it was scheduled for February 14, 2024 got closed January 5th see both S-4/A for reference

"The BCA may be terminated by either Pono or Horizon if the Closing has not occurred by February 14, 2024 (unless Pono extends the period of time it has to consummate a business combination)."

So expect news

Pono shareholders approved news January 5th news at 3pm expectations was for February 14, 2024

8k Monday/Tuesday?
4 business days

Redwood acquisition Corp celebrating forgot to release 8k ? 😉

Anew Medical Inc celebrating 🎉👏🎉

As of January 5th no changes/extensions to January 4th 2024 combination closed date per
S-4/A January 3rd 2024 filling

"The Business Combination is expected to close, and the S4 is expected to be effective, in the fourth calendar quarter of 2023, but in no event later than January 4, 2024, following the receipt of the required approval by the stockholders of Redwoods and of ANEW, approval by the Nasdaq Stock Market (“Nasdaq”) of the initial listing application of the combined company filed in connection with the Business Combination, and the fulfillment of other customary closing conditions."


Key notes:

"If Redwoods does not complete a business combination with ANEW or another target business by January 4, 2024"

"The completion window ends on January 4, 2024 (unless otherwise extended in accordance with Redwoods’ charter);"

"On November 27, 2023, Redwoods made a cash contribution of $35,000 to the trust account to extend the business combination period from December 4, 2023 to January 4, 2024. As of [•], 2023, the record date for the special meeting, there was approximately $[•] held in the trust account."

"if Redwoods is unable to complete a business combination prior to January 4, 2024 (unless otherwise extended in accordance with Redwoods’ charter)."
Anticipating Material filling

Per filling BCA March 4th deadline. News any moments . Human clinical trails starts 2024 the BCA runs parallel to the cut of date so any moment now especially no so sign of extended combination date changes/additional $35k for February.

Should expect news of new CFO

There should be another s-4/a for another month if January 4th changes an additional $35k to extend if not 8K

"On November 27, 2023, Redwoods made a cash contribution of $ 35,000 to the Trust Account to extend the business combination period from December 4, 2023 to January 4, 2024."

pay closed attention to both below. The completion combination close date for January 4, 2024 didn't changed even though within the s-4/a fillings votes for December 2023* were reaffirmed which is 3 days already into 2024 on January 3rd 2024
Expecting material events however the BCA termination date is set for March 4th 2024

"On November 4, 2023, Redwoods and ANEW entered into Amendment No.1 to the BCA, pursuant to which the termination date under the BCA was extended to March 4, 2024."

January 3, 2024 - S-4/A: Registration of securities, business combinations - amendment Open document Filing Open filing

December 4, 2023 - S-4/A: Registration of securities, business combinations - amendment Open document Filing Open filing

Seems like a DONE DEAL and waiting on 8k.

"Biosimilar Competition"

"ANEW will face competition in the US, European and other markets from the innovator brand in that market, from biosimilars already approved in those markets, and from biosimilars still in development in those markets. Major players in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., and Celltrion Healthcare Co. Ltd., Sandoz International GmbH, Reliance Life Sciences, C.H. Boehringer Sohn AG & Co. KG, BioXpress Therapeutics SA, and Intas Biopharmaceuticals Ltd. There are two other Avastin biosimilars, Mvasi (bevacizumab-awwb), co-developed by Amgen and Allergan, and Pfizer’s Zirabev (bevacizumab-bvzr).

In Europe, due to immediate acceptance by physicians and government agencies of potential savings due to the price competition of biosimilars, the prices of the innovator’s products came down by 30%-40% or more because of the lower retail prices of the biosimilar product once approved by EMA, whereas in the U.S., biosimilar products approved by FDA are priced at nearly the same price of the innovator’s product. Now, with improving acceptance of biosimilar products in the U.S., prices of both the biosimilar and innovator’s products are coming down, and significant savings are now being realized by the insurance companies and other payors in the U.S."

Agreed! Per fillings

"Avastin® and Rituxan®/Mabthera® are the brand names of bevacizumab and rituximab. Both Genentech in the U.S. and Roche in Switzerland manufacture these antibodies. Rituximab is marketed as Rituxan® in the US and Japan, and branded as Mabthera® outside the US and Japan.

The approved indications for these antibodies are as follows:

Rituxan® (rituximab) is indicated for the treatment of adult patients with Non-Hodgkin’s Lymphoma (NHL) — Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent, Previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to a rituximab product in combination with chemotherapy, as single-agent maintenance therapy, Non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL, as a single agent, after first-line CVP chemotherapy, Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens. Rituxan is indicated for the treatment of pediatric patients aged 6 months and older with mature B-cell NHL and mature B-cell acute leukemia (B-AL), Previously untreated, advanced stage, CD20-positive, diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma (BLL) or mature B-cell acute leukemia (B-AL) in combination with chemotherapy. Rituxan is indicated for the treatment of adult patients with previously untreated and previously treated CD20-positive Chronic Lymphocytic Leukemia (CLL) in combination with fludarabine and cyclophosphamide (FC).

135

what is shaping up to be a eye opener. Anew Biosimilar. Most recently FDA approved

FDA Approves Avzivi, the Fifth Biosimilar to Avastin
Dec 19, 2023

"The US Food and Drug Administration (FDA) has approved Avzivi (bevacizumab-tnjn), a biosimilar to Avastin (bevacizumab)."


Note: What is the difference between Avastin and bevacizumab?
Bevacizumab is a type of targeted cancer drug treatment. It is also known as Avastin. It is a treatment for a number of different cancer types.

Note below "Avastin" noticed it said to be similar to "Genentech/Roche"

Anew Medical Inc website

"We are focused on commercializing several blockbuster biologic drugs (antibodies) whose patents have expired and have been proven by our corporate partner to be highly similar to the Genentech/Roche reference antibodies already on the market. These antibody products are referred to as “biosimilars” or “biogenerics”. Our exclusively-licensed portfolio consists biosimilars of Roche/Genentech’s bevacizumab (anti-VEGF, Avastin®) and rituximab (anti-CD20, Mabthera® and Rituxan®).

These two antibody products still provide annual revenue of over $16 Billion to the Roche/Genentech franchise. These are extremely important biologic drugs that are the mainstay or “gold standard” in the treatment of human solid tumors (bevacizumab)."

"a reverse split will no longer be necessary as the combined company will be renamed ANEW MEDICAL Inc. "

F-81

https://www.sec.gov/ix?doc=/Archives/edgar/data/1907223/000121390024000608/fs42023a4_redwoodsacq.htm

And for good reasons.. "I Here we used a CRISPR-dCas9 complex to investigate single-guide RNA (sgRNA) targeting the Klotho promoter region for efficient transcriptional activation of the Klotho gene. We tested the sgRNAs within the - 1 to - 300 bp of the Klotho promoter region and identified two sgRNAs that can effectively enhance Klotho gene transcription. We examined the transcriptional activation of the Klotho gene using three different systems: a Firefly luciferase (FLuc) and NanoLuc luciferase (NLuc) coincidence reporter system, a NLuc knock-in in Klotho 3'-UTR using CRISPR genomic editing"

https://pubmed.ncbi.nlm.nih.gov/29352444/

A voluntary delisting may occur when a company determines that there is no longer a financial benefit to being publicly traded. A buyout: In a buyout, the purchasing entity often takes the purchased company private.

Brock took over everything start to change. Buyout potential/merger. Now they can make. Moves and not be pressured by nasdaq


"I have full faith in Brock's stewardship abilities to lead the company," said Kaspien Board member and Company Co-Founder Tom Simpson. "Brock knows Kaspien and our partners inside and out, and his financial and operational acumen are unmatched. Over the last four years, he has earned and maintained the respect from employees throughout the organization. Brock brings the right combination of vision, pragmatism, and humanity needed to drive a relationship-centric business such as ours."

Now fireweed comes out after 1 year and throw it into the world face and said the real value.
I still hold my shares.. it sad that this goes for penny on the dollar and certain folks kept talking down this potential now we see the real value comes out.

Who bought shares recently at .0001? Shake my head

"The current Mineral Resource at Mactung ranks it the largest high-grade tungsten resource in the world and it is a clear statistical outlier in terms of grade and contained metal*. It is a tungsten skarn deposit associated with Tombstone-Tungsten suite granitic intrusions that are more broadly linked to a variety of gold and tungsten deposits across Yukon-Northwest Territories. The Mactung deposit is sub-divided into an upper and lower zone that both occur at surface and extend to depths of approximately 400 m below surface."




https://finance.yahoo.com/news/fireweed-metals-announces-mineral-resources-151400406.html

The truth about the real value. They gave this away for little to nothing


https://finance.yahoo.com/news/fireweed-metals-announces-mineral-resources-151400406.html

Fireweed Metals Announces Mineral Resources for the Mactung Project: the Largest High-Grade Tungsten Deposit in the World*

"CEO Statement

Brandon Macdonald, CEO, stated “In one year we have gone from signing an initial Letter of Intent to a Definitive Asset Purchase Agreement to the publication of new mineral resource for Mactung. We have taken the historic resource through a process involving relogging, resampling, and a rigorous, modern estimation methodology, and confirmed an impressive and world-class tungsten resource at Mactung*. This not only reaffirms Mactung's unmatched combination of grade and scale but establishes it as a truly strategic critical minerals project for the West with the underground resource alone able to supply much of North America’s expected demand for decades. Fireweed is looking forward to collaborating with federal, territorial, and Indigenous governments to advance Mactung through the permitting and detailed engineering stages of this unique project.”

Checked on this a week ago.. got them shares .. let's see if my account change lol good news

Maybe this have a merger potential down the road. Cantung Mine still up for sale.

Cantung next

Mactung sold Newsss

https://cabinradio.ca/96202/news/economy/nwt-agrees-sale-of-mactung-property-for-up-to-15m/

Brilliant!

"If you dont know" now ya know"